Daoud Dane Christina, Schwenger Katherine J P, Ghorbani Yasaman, Gramlich Leah, Ou George, Armstrong David, Raman Maitreyi, Allard Johane P, Bielawska Barbara
Department of Medicine, Division of Gastroenterology, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Department of Medicine, Division of Gastroenterology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
JPEN J Parenter Enteral Nutr. 2025 Aug;49(6):773-782. doi: 10.1002/jpen.2772. Epub 2025 May 23.
Metabolic and bariatric surgery is one of the most efficacious treatments for obesity. The increasing incidence of referrals to intestinal rehabilitation programs and the necessity for long-term parenteral nutrition because of bariatric surgery complications have gained attention, yet data remain limited. Our objectives were to (1) assess parenteral nutrition-related complication rates of patients requiring long-term parenteral nutrition because of bariatric surgery complications and (2) compare outcomes between types of metabolic and bariatric surgery.
This was a descriptive cohort (n = 25) study, which gathered data from patients enrolled in the national registry with a history of metabolic and bariatric surgery at baseline and 2 years and included demographics, biochemical parameters, parenteral regimens, line sepsis, hospitalizations, and functional status.
In this study, 92% were women with a mean age of 53.8 ± 8.6 years. The most prevalent procedure performed was Roux-en-Y gastric bypass (60%). Short bowel syndrome was observed in 40% of our cohort (n = 10). After 2 years, there was a significant reduction in the need for parenteral nutrition compared with baseline, with 37.5% of patients achieving weaning. No significant disparities were observed in the incidence of line sepsis, hospitalizations, or Karnofsky performance status between baseline and the 2-year follow-up, regardless of the type of surgery. Roux-en-Y gastric bypass was associated with lower body mass index at the 2-year mark.
In post-metabolic and bariatric surgery patients, long-term parenteral nutrition is well tolerated based on clinical outcomes and functional status is not influenced by the type of surgery.
代谢与减重手术是治疗肥胖最有效的方法之一。因减重手术并发症而转诊至肠道康复项目的发生率不断上升,以及长期肠外营养的必要性已受到关注,但相关数据仍然有限。我们的目标是:(1)评估因减重手术并发症而需要长期肠外营养的患者的肠外营养相关并发症发生率;(2)比较不同类型代谢与减重手术的结果。
这是一项描述性队列研究(n = 25),收集了国家登记处中基线时和2年时有代谢与减重手术史的患者的数据,包括人口统计学、生化参数、肠外营养方案、导管相关感染、住院情况和功能状态。
在本研究中,92%为女性,平均年龄53.8±8.6岁。最常见的手术是Roux-en-Y胃旁路术(60%)。我们队列中有40%(n = 10)的患者出现短肠综合征。2年后,与基线相比,肠外营养需求显著减少,37.5%的患者实现了脱机。无论手术类型如何,基线和2年随访之间在导管相关感染、住院率或卡氏功能状态方面均未观察到显著差异。Roux-en-Y胃旁路术在2年时与较低的体重指数相关。
在代谢与减重手术后的患者中,基于临床结果,长期肠外营养耐受性良好,功能状态不受手术类型的影响。